Related references
Note: Only part of the references are listed.Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras
Michael J. Cavnar et al.
ANNALS OF SURGERY (2021)
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-Ping Xu et al.
GUT (2020)
RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy
Ziyou Lin et al.
EMBO JOURNAL (2020)
Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy
Mustafa Nazzal et al.
HEPATOLOGY (2020)
GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia
Seung Hun Han et al.
AUTOPHAGY (2019)
Biological Functions of Autophagy Genes: A Disease Perspective
Beth Levine et al.
CELL (2019)
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Dual role of autophagy in hallmarks of cancer
Shikha Satendra Singh et al.
ONCOGENE (2018)
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib
Kai Zhang et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study
Silvia Stacchiotti et al.
CANCER (2018)
Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence
Haoran Tai et al.
AUTOPHAGY (2017)
New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies
Leilei Niu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Silvia Stacchiotti et al.
CLINICAL CANCER RESEARCH (2016)
Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
Ying Lu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
Jiang Chen et al.
CANCER LETTERS (2015)
Targeting autophagy to overcome drug resistance in cancer therapy
Ankit Kumar et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Historical landmarks of autophagy research
Yoshinori Ohsumi
CELL RESEARCH (2014)
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
Brian M. Wolpin et al.
ONCOLOGIST (2014)
Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors
Christine Victoria Ichim
STEM CELLS TRANSLATIONAL MEDICINE (2014)
KIT oncogene inhibition drives intratumoral macrophage M2 polarization
Michael J. Cavnar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Adjuvant treatment of GIST: patient selection and treatment strategies
Heikki Joensuu
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment
Lisa C. Crowley et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
Ying-Hong Shi et al.
AUTOPHAGY (2011)
Autophagy: Renovation of Cells and Tissues
Noboru Mizushima et al.
CELL (2011)
Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST)
Anu Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Autophagy Suppresses Tumorigenesis through Elimination of p62
Robin Mathew et al.
CELL (2009)
Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells
Takashi Shingu et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
Cristian Bellodi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Imatinib and beyond-exploring the full potential of targeted therapy for CML
Alfonso Quintas-Cardama et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Selective turnover of p62/A170/SQSTM1 by autophagy
Yoshinobu Ichimura et al.
AUTOPHAGY (2008)
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy
Serhiy Pankiv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Atsuko Nakai et al.
NATURE MEDICINE (2007)
The anticancer drug imatinib induces cellular autophagy
A. Ertmer et al.
LEUKEMIA (2007)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death
G Bjorkoy et al.
JOURNAL OF CELL BIOLOGY (2005)
Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer
NC Wolff et al.
CLINICAL CANCER RESEARCH (2004)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
